Business

Uptick Newswire interviews Applied BioSciences for The First time on the Stock Day Radio podcast and Discuses the Growth of Their CBD Product Lines

Uptick Newswire interviews Applied BioSciences for The First time on the Stock Day Radio podcast and Discuses the Growth of Their CBD Product Lines.

articleApplied Biosciences Corp.November 26, 20183/company/applied-biosciences-corp/news/uptick-newswire-interviews-applied-biosciences-for-the-first-time-on-the-stock-day-radio-podcast-and-discuses-the-growth-of-their-cbd-product-lines
Uptick Newswire interviews Applied BioSciences for The First time on the Stock Day Radio podcast and Discuses the Growth of Their CBD Product Lines

About this update from Applied Biosciences Corp.

[{"type":"text","content":"LOS ANGELES, CA / ACCESSWIRE / November 26, 2018 / Applied BioSciences Corp. (OTCQB: APPB) is a diversified cannabinoid therapeutics company that specializes in the medical,bioceutical, and pet health industries. The President of Applied BioSciences, Chris Bridges, joined Stock Day's Everett Jolly for the first time to discuss the Company's newly expanded product line, as well as their goals for growth going forward. Jolly began the interview by asking Bridges for a little bit of background information on the Company, as well as himself. Bridges responded, "We're a diversified company focused primarily on the CBD market. We have several different brands under our umbrella." Bridges went on to explain that these included consumer-based brands and their product lines, as well as Herbal Pet, which is a pet-focused brand.Speaking of his own background, Bridges the stated, "Primarily my background is as a tech entrepreneur and in the payment space. I have been building companies since I was in my early 20's, and came onboard with Applied BioSciences about two years ago and have been really excited about building this company."Jolly noted the crowded CBD industry given the recent popularity of these products and then asked, "What makes your CBD products so special?" Bridges expanded on the uniqueness of his product line and explained, "What makes our products special is that they are completely organic and free of poisons and pesticides. We have done a great job at creating the best-in-class CBD products out there."Bridges then discussed the estimated growth of the CBD market, noting that by 2022 this industry will be worth around $22 Billion. Bridges added, "What drove us to create these product lines was focusing on specific targets. We're looking to achieve products that really solve specific problems."The interview then turned to the discussion of one of the Company's brands, Herbal Pet, which has been growing steadily as a pet line under Bridge's leadership. Jolly inquired, "When is this brand really going to come to fruition and how big is the demand for this segment?"Bridges responded, "We're starting to push the direct to consumer sales, as well as wholesale for the products. There's a massive and explosive growth for pet-oriented products around CBD. We're reall...

More updates from Applied Biosciences Corp.